TECVAYLI

A Phase 1b Trial of Teclistamab in Combination With Iberdomide for Relapsed/Refractory Multiple Myeloma

Near Add Your Location

Sorting 9 by

Dana-Farber Cancer Institute
Boston, MA
  • Accepting patients
  • Show Principal Investigator
Massey Cancer Center
Virginia Commonwealth University (VCU Health)
Richmond, VA
  • Accepting patients
Ohio State University Comprehensive Cancer Center
James Cancer Hospital and Solove Research Institute
Columbus, OH
  • Accepting patients
Moffitt Cancer Center
Magnolia Campus
Tampa, FL
  • Accepting patients
North Haven Medical Center
Yale-New Haven Hospital
North Haven, CT
  • Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.